Predict your next investment

HEALTHCARE | Drug Development
vensunrx.com

See what CB Insights has to offer

Executives

4

Board of Directors

4

Vensun Pharmaceuticals Board of Directors

4 Board of directors

Vensun Pharmaceuticals has 4 board of directors, including Dhananjay Wadekar.

Name

Firm

Work History

Other Seats

Dhananjay Wadekar

Jason Wild

Jason Wild is the President and Chief Investment Officer of JW Asset Management, the advisor for three investment partnerships. Mr. Wild received his license as a pharmacist in 1997, and subsequently founded JW Asset Management in 1998. The firm has a strong history of finding opportunities within the specialty pharmaceutical sector. He is a graduate of the Arnold and Marie Schwartz College of Pharmacy where he received a bachelor’s degree in Pharmacy.

Kamlesh Haribhakti

Syed Abidi

Name

Dhananjay Wadekar

Jason Wild

Kamlesh Haribhakti

Syed Abidi

Firm

Work History

Jason Wild is the President and Chief Investment Officer of JW Asset Management, the advisor for three investment partnerships. Mr. Wild received his license as a pharmacist in 1997, and subsequently founded JW Asset Management in 1998. The firm has a strong history of finding opportunities within the specialty pharmaceutical sector. He is a graduate of the Arnold and Marie Schwartz College of Pharmacy where he received a bachelor’s degree in Pharmacy.

Other Seats

Vensun Pharmaceuticals Management Team

4 Team Members

Vensun Pharmaceuticals has 4 executives. Vensun Pharmaceuticals's current Chief Executive Officer, President is Hemanshu Pandya.

Name

Work History

Title

Status

Hemanshu Pandya

Chief Executive Officer, President

Current

Kamlesh Haribhakti

Executive Vice President

Current

Joshua Gordon

Senior Vice President

Current

Joan Janulis

Senior Vice President

Current

Name

Hemanshu Pandya

Kamlesh Haribhakti

Joshua Gordon

Joan Janulis

Work History

Title

Chief Executive Officer, President

Executive Vice President

Senior Vice President

Senior Vice President

Status

Current

Current

Current

Current

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.